comparemela.com

Latest Breaking News On - Shweta munjal - Page 1 : comparemela.com

Lupin : December 27, 2023 Lupin Receives Approval from U.S. FDA for Loteprednol Etabonate Ophthalmic Suspension, 0.2% -December 27, 2023 at 03:42 pm EST

Mumbai, Baltimore, December 27, 2023: Global pharma major Lupin Limited today announced that it has received approval from the United States Food and Drug Administration for its.

Mumbai
Maharashtra
India
United-states
South-africa
Asia-pacific
Shweta-munjal
Linkedin
Facebook
Bausch-lomb-inc
Lupin-limited
Drug-administration

Lupin : December 15, 2023 Lupin Receives Approval from U.S. FDA for Allopurinol Tablets -December 15, 2023 at 07:03 am EST

Mumbai, Baltimore, December 15,2023: Global pharma major Lupin Limited today announced that it has received approval from the United States Food and Drug Administration for its.

India
United-states
Mumbai
Maharashtra
South-africa
Shweta-munjal
Asia-pacific
Casper-pharma
Linkedin
Twitter
Biotechnology-pharmaceuticals
Drug-administration

Lupin : December 15, 2023 Lupin Receives Tentative Approval from U.S. FDA for Sitagliptin Tablets -December 15, 2023 at 06:52 am EST

Mumbai, Baltimore, December 15, 2023: Global pharma major Lupin Limited today announced that it has received tentative approval from the United States Food and Drug Administration for.

Mumbai
Maharashtra
India
South-africa
United-states
Asia-pacific
Shweta-munjal
Linkedin
Drug-administration
Facebook
Twitter
Corporate-communications

Lupin : November 21, 2023 Lupin Receives Tentative Approval from U.S. FDA for Dapagliflozin Tablets -November 21, 2023 at 05:04 am EST

Mumbai, Baltimore, November 21, 2023: Global pharma major Lupin Limited today announced that it has received tentative approval from the United States Food and Drug Administration for.

India
South-africa
United-states
Mumbai
Maharashtra
Shweta-munjal
Asia-pacific
Linkedin
Lupin-limited
Biotechnology-pharmaceuticals
Drug-administration
Corporate-communications-sustainability

Lupin : November 21, 2023 Lupin Receives Approval from U.S. FDA for Pitavastatin Tablets -November 21, 2023 at 05:26 am EST

Mumbai, Baltimore, November 21,2023: Global pharma major Lupin Limited today announced that it has received approval from the United States Food and Drug Administration for its.

Mumbai
Maharashtra
India
United-states
South-africa
Asia-pacific
Shweta-munjal
Lupin-limited
Linkedin
Facebook
Kowa-company
Corporate-communications-sustainability

vimarsana © 2020. All Rights Reserved.